Digirad Co. (NASDAQ:DRAD) Director Jeffrey E. Eberwein bought 300,000 shares of Digirad stock in a transaction dated Tuesday, September 10th. The stock was acquired at an average price of $10.00 per share, with a total value of $3,000,000.00. Following the purchase, the director now directly owns 4,419 shares of the company’s stock, valued at $44,190. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Shares of DRAD stock traded up $0.29 during trading hours on Thursday, reaching $4.90. The stock had a trading volume of 84,756 shares, compared to its average volume of 10,554. The stock’s fifty day simple moving average is $4.80 and its 200 day simple moving average is $3.13. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.42 and a quick ratio of 1.03. Digirad Co. has a 12 month low of $4.20 and a 12 month high of $15.90.
Digirad (NASDAQ:DRAD) last released its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $0.04 EPS for the quarter. Digirad had a negative net margin of 5.81% and a negative return on equity of 10.97%. The company had revenue of $25.80 million during the quarter.
Separately, ValuEngine lowered shares of Digirad from a “buy” rating to a “hold” rating in a research report on Tuesday, July 2nd.
Digirad Company Profile
Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services.
Featured Article: What is a Backdoor Roth IRA?
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.